Levomedical
  • Home
  • Therapy
    • How it works
    • How to get started
    • Levo Gen 2
    • FAQ
  • For Professionals
    • Why Levo Gen 2
    • Platform features
    • Care models
  • Resources
  • Start Evaluation
Select Page
FDA 510(k) clearance of the Levo Gen 2 Tinnitus Therapy System (K260413)

FDA 510(k) clearance of the Levo Gen 2 Tinnitus Therapy System (K260413)

by Jose Ignacio Duro | Aug 13, 2026 | FDA & patents

U.S. Patent 9,301,714 B2: systems and methods for tracking and presenting tinnitus therapy data

U.S. Patent 9,301,714 B2: systems and methods for tracking and presenting tinnitus therapy data

by Jose Ignacio Duro | Apr 5, 2016 | FDA & patents

U.S. Patent 9,282,917 B2: systems and methods for tinnitus therapy

U.S. Patent 9,282,917 B2: systems and methods for tinnitus therapy

by Jose Ignacio Duro | Mar 15, 2016 | FDA & patents

FDA 510(k) clearance of the first-generation Levo System (K140845)

FDA 510(k) clearance of the first-generation Levo System (K140845)

by Jose Ignacio Duro | Jul 18, 2014 | FDA & patents

  • Follow
  • Follow
  • Follow
  • Follow


+1 (866) 306-1387



info@levomedical.com

Regulatory Info

Privacy Policy

© 2026 Levo Medical Corporation

Levomedical updates

Research, resources and clinical advances on tinnitus, straight to your inbox.

No spam. Unsubscribe anytime. Privacy Policy

Almost there! We have sent you an email to confirm your subscription. Check your inbox (or spam folder) and click the confirmation button.

Request to join the Levo Clinical Network

Tell us about your practice to request an informational meeting.


0 / 180